4basebio - Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Registrars:

Key Personnel

CEO: Heikki Lanckriet
CFO: David John Roth
Non-Executive Director: Hansjörg Plaggemars, Joseph Manuel Fernández
Non-Executive Chairman: Timothy Paul McCarthy
Independent Non-Executive Director: Maria Del Pilar de la Huerta, Alan Malus
Chief Operating Officer: Amy Walker

Contact Details

Address: 25 Norman Way, Over, Cambridge, United Kingdom
Phone: +44 (0)1223 967943
Fax:
Website: http://www.4basebio.com/
Email:

Listings

ISIN: GB00BMCLYF79
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share